Bone demineralization in rheumatoid arthritis

Area of Science:

• Rheumatology
• Orthopedics
• Pharmacology

Background:

• Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting joints.
• RA management often involves corticosteroids, which can have systemic side effects.
• Bone health is a significant concern in RA patients due to inflammation and treatment side effects.

Purpose of the Study:

• To investigate the impact of physical activity levels on bone health in RA patients.
• To assess the relationship between corticosteroid dosage and bone mineral density in RA patients.
• To quantify the annual rate of cortical bone loss in different patient groups.

Main Methods:

• Cross-sectional study of 210 RA patients categorized by mobility (exercising, non-exercising, immobilized).
• Longitudinal assessment of bone mineral density (clavicular cortico-diaphyseal index) over two years.
• Analysis of bone thickness in 153 RA patients based on daily corticosteroid (prednisolone) dosage.

Main Results:

• Exercising RA patients exhibited higher clavicular bone indices compared to immobilized patients.
• Annual cortical bone loss was lowest in the exercising group (-2.19%) and highest in the immobilized group (-8.94%).
• Higher daily prednisolone doses (12.5-20 mg) were associated with significantly greater annual bone loss (>10%) than lower doses (5-10 mg, 7%).

Conclusions:

• Physical activity is protective against bone loss in rheumatoid arthritis.
• Corticosteroid therapy, particularly at higher daily doses, accelerates cortical bone loss in RA patients.
• Optimizing physical activity and steroid management is crucial for preserving bone health in RA.